(Eagle News) – Russia’s anti-COVID-19 vaccine Sputnik V has been given emergency use authorization (EUA) by the Food and Drug Administration (FDA), the agency’s director general said. FDA Director General Undersecretary Eric Domingo said that they issued the EUA to Sputnik V manufactured by Russia’s Gamaleya Research Institute after a “rigorous and thorough review.” Sputnik V even has a higher efficacy rate against COVID-19 at 91.6 percent, which is higher than the 63.09% against […]
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.